The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6–11 with cystic fibrosis in a real-world setting. - McNally, Paul; Linnane, Barry; Williamson, Michael; Elnazir, Basil; Short, Christopher; Saunders, Clare; Kirwan, Laura; David, Rea; Kemner-Van de Corput, Mariette P. C.; Tiddens, Harm A.W.M.; Davies, Jane C; Cox, Des W (Respiratory Research, 2023)